115 Recruiting Acute Lymphoblastic Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Acute Lymphoblastic Leukemia
Related Conditions
Top Recruiting Acute Lymphoblastic Leukemia Studies
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Transcranial Direct Current Stimulation of the Temporal Cortex in Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
📍 Mount Sinai Hospital — New York, New York
View Study & Checklist ➔A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
📍 Emory University Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔MT2017-45: CAR-T Cell Therapy for Heme Malignancies
📍 Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
📍 Kaiser Permanente-Oakland — Oakland, California
View Study & Checklist ➔A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Administration of Donor T Cells With the Caspase-9 Suicide Gene
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
View Study & Checklist ➔Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma
📍 Children's Hospital Boston — Boston, Massachusetts
View Study & Checklist ➔Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
View Study & Checklist ➔Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
📍 Novant Health Presbyterian Hemby Children's Hospital — Charlotte, North Carolina
View Study & Checklist ➔European Prospective Investigation Into Childhood Cancer
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
📍 Columbia University Medical Center — New York, New York
View Study & Checklist ➔Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
📍 Vancouver General Hospital — Vancouver, British Columbia
View Study & Checklist ➔Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔